These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22838113)

  • 1. [The HUS epidemic in the summer of 2011 was severe. German and Swedish experiences of the EHEC outbreak].
    Samuelsson O; Follin P; Rundgren M; Rylander C; Selga D; Ståhl A
    Lakartidningen; 2012 Jun 19-26; 109(25):1230-4. PubMed ID: 22838113
    [No Abstract]   [Full Text] [Related]  

  • 2. [Escherichia coli associated hemolytic and uremic syndrome: what lessons can be learned after the European epidemic of 2011?].
    Lemaignen A; Ridel C; Hertig A; Rondeau E
    Nephrol Ther; 2013 Jun; 9(3):129-36. PubMed ID: 23266201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemic of EHEC (Escherichia coli O104:H4) in Europe in 2011--clinical and therapeutic problems].
    Simon K; Janocha J
    Przegl Epidemiol; 2012; 66(1):73-7. PubMed ID: 22708302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
    Kielstein JT; Beutel G; Fleig S; Steinhoff J; Meyer TN; Hafer C; Kuhlmann U; Bramstedt J; Panzer U; Vischedyk M; Busch V; Ries W; Mitzner S; Mees S; Stracke S; Nürnberger J; Gerke P; Wiesner M; Sucke B; Abu-Tair M; Kribben A; Klause N; Schindler R; Merkel F; Schnatter S; Dorresteijn EM; Samuelsson O; Brunkhorst R;
    Nephrol Dial Transplant; 2012 Oct; 27(10):3807-15. PubMed ID: 23114903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent outbreak of hemolytic uremic syndrome in Germany.
    Kunzendorf U; Karch H; Werber D; Haller H
    Kidney Int; 2011 Nov; 80(9):900-2. PubMed ID: 21997502
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.
    Frank C; Werber D; Cramer JP; Askar M; Faber M; an der Heiden M; Bernard H; Fruth A; Prager R; Spode A; Wadl M; Zoufaly A; Jordan S; Kemper MJ; Follin P; Müller L; King LA; Rosner B; Buchholz U; Stark K; Krause G;
    N Engl J Med; 2011 Nov; 365(19):1771-80. PubMed ID: 21696328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious diseases. As E. coli outbreak recedes, new questions come to the fore.
    Kupferschmidt K
    Science; 2011 Jul; 333(6038):27. PubMed ID: 21719654
    [No Abstract]   [Full Text] [Related]  

  • 8. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.
    Werber D; King LA; Müller L; Follin P; Buchholz U; Bernard H; Rosner B; Ethelberg S; de Valk H; Höhle M
    Am J Epidemiol; 2013 Sep; 178(6):984-92. PubMed ID: 23935124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A German outbreak of haemolytic uraemic syndrome.
    Ruggenenti P; Remuzzi G
    Lancet; 2011 Sep; 378(9796):1057-8. PubMed ID: 21871656
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical symptoms, treatment and outcome of EHEC and EHEC-HUS patients treated as in-patients].
    Dücker C; Dautel P; Wagner K; Przewozna J; Oehlerking S; Repenthin J; Brüning R; Meyer TN; Faiss S
    Dtsch Med Wochenschr; 2011 Sep; 136(36):1770-6. PubMed ID: 21882131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab.
    Ağbaş A; Göknar N; Akıncı N; Yıldırım ZY; Taşdemir M; Benzer M; Gökçe İ; Candan C; Küçük N; Uzuner S; Özçelik G; Demirkol D; Sever L; Çalışkan S
    Pediatr Nephrol; 2018 Dec; 33(12):2371-2381. PubMed ID: 30159625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outbreak of Shiga toxin-producing Escherichia coli and haemolytic uraemic syndrome].
    Kuijper EJ; Timen A; Franz E; Wessels E; van Dissel JT
    Ned Tijdschr Geneeskd; 2011; 155(35):A3743. PubMed ID: 21902849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections.
    Wu CJ; Hsueh PR; Ko WC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):390-3. PubMed ID: 21862425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological analysis of a cluster within the outbreak of Shiga toxin-producing Escherichia coli serotype O104:H4 in Northern Germany, 2011.
    Scharlach M; Diercke M; Dreesman J; Jahn N; Krieck M; Beyrer K; Claußen K; Pulz M; Floride R
    Int J Hyg Environ Health; 2013 Jun; 216(3):341-5. PubMed ID: 23154087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective.
    Kemper MJ
    Pediatr Nephrol; 2012 Feb; 27(2):161-4. PubMed ID: 22160440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli O104:H4 outbreak from sprouted seeds.
    Soon JM; Seaman P; Baines RN
    Int J Hyg Environ Health; 2013 Jun; 216(3):346-54. PubMed ID: 22898546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "HUS diary" of a German nephrologist during the current EHEC outbreak in Europe.
    Harendza S
    Kidney Int; 2011 Oct; 80(7):687-9. PubMed ID: 21734639
    [No Abstract]   [Full Text] [Related]  

  • 18. The German 2011 epidemic of Shiga toxin-producing E. Coli--the nephrological view.
    German EHEC-HUS Registry
    Nephrol Dial Transplant; 2011 Sep; 26(9):2723-6. PubMed ID: 21852273
    [No Abstract]   [Full Text] [Related]  

  • 19. The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.
    Magnus T; Röther J; Simova O; Meier-Cillien M; Repenthin J; Möller F; Gbadamosi J; Panzer U; Wengenroth M; Hagel C; Kluge S; Stahl RK; Wegscheider K; Urban P; Eckert B; Glatzel M; Fiehler J; Gerloff C
    Brain; 2012 Jun; 135(Pt 6):1850-9. PubMed ID: 22539260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.
    Menne J; Nitschke M; Stingele R; Abu-Tair M; Beneke J; Bramstedt J; Bremer JP; Brunkhorst R; Busch V; Dengler R; Deuschl G; Fellermann K; Fickenscher H; Gerigk C; Goettsche A; Greeve J; Hafer C; Hagenmüller F; Haller H; Herget-Rosenthal S; Hertenstein B; Hofmann C; Lang M; Kielstein JT; Klostermeier UC; Knobloch J; Kuehbacher M; Kunzendorf U; Lehnert H; Manns MP; Menne TF; Meyer TN; Michael C; Münte T; Neumann-Grutzeck C; Nuernberger J; Pavenstaedt H; Ramazan L; Renders L; Repenthin J; Ries W; Rohr A; Rump LC; Samuelsson O; Sayk F; Schmidt BM; Schnatter S; Schöcklmann H; Schreiber S; von Seydewitz CU; Steinhoff J; Stracke S; Suerbaum S; van de Loo A; Vischedyk M; Weissenborn K; Wellhöner P; Wiesner M; Zeissig S; Büning J; Schiffer M; Kuehbacher T;
    BMJ; 2012 Jul; 345():e4565. PubMed ID: 22815429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.